Money / Martin Shkreli Why CEO Hasn't Cut Drug's 5K% Price Hike Turing chief Martin Shkreli says it will be a 'long' process to figure out demand By Jenn Gidman Posted Oct 14, 2015 10:48 AM CDT Copied Back